Growth Supports Tekton’s Strategic Focus in CNS and Cardiometabolic Research AUSTIN, TX – October 2, 2025 — Tekton Research, a leading multi-site clinical trial company, is pleased to announce the promotion of Corey A. Collins to Chief Executive Officer (CEO). Collins joined Tekton in December 2023 as Chief Financial Officer, bringing over 20 years of … Read more
Growth supports Tekton’s strategic focus on CNS and Cardiometabolic research AUSTIN, TX – September 26, 2025 — Tekton Research, a leading multi-site clinical trial company, is proud to announce the addition of three new sites, five new Principal Investigators (PIs), and a renowned CNS Consultant to its expanding network. These additions reflect Tekton’s continued commitment … Read more
Initial Collaboration Launches at Yukon, OK Site Austin, TX — July 1, 2025 – Tekton Research is proud to announce a new strategic partnership with Summit Clinical Research, a leading Integrated Research Organization focused on solving the challenges of MASH/NASH clinical trials. The collaboration marks Tekton’s entry into MASH (Metabolic dysfunction-associated steatohepatitis) research, further expanding … Read more
Austin, TX – June 10, 2025 – Tekton Research continues its strategic growth in 2025 with the addition of its fourth new research site this year. The latest partnership is with Richmond Pediatric Associates, a respected multi-physician clinic in Virginia known for delivering comprehensive care across pediatric and adolescent populations. The site brings added pediatric … Read more
Midlothian, VA — Tekton Research is proud to welcome Ben Phillips, MD, a board-certified endocrinologist and leader in diabetes, obesity, and osteoporosis care, as a Principal Investigator. This partnership expands Tekton’s clinical research footprint into the Midlothian and Richmond, Virginia region. With over 25 years of clinical experience, Dr. Phillips brings deep expertise in treating … Read more
Each year on May 20, we pause to honor Clinical Trials Day–a global recognition of the people, partnerships and progress that make clinical research possible. This day marks the anniversary of the first randomized clinical trial, conducted in 1747 by James Lind, and serves as a moment to reflect on how far we’ve come–and where … Read more
Saint Louis, MO – Tekton Research is proud to announce its partnership with Dr. Ernest A. Graypel, a highly regarded psychiatrist and researcher, Board Certified in Psychiatry and Neurology. This effort supports Tekton’s expanding capabilities in central nervous system (CNS) research, particularly in Behavioral Health sciences. As the Medical Director of Community and Long-Term Care … Read more
As we step into 2025, Tekton Research is proud to reflect on a year filled with growth, innovation, and impactful contributions to clinical research. Tekton extends their gratitude to everyone who played a role in advancing their mission. From the dedicated staff and PI’s, to CRO and biopharma partners, and patients, who generously participated in … Read more
Marlboro, NJ – Tekton Research is pleased to announce that Amor R. Mehta, MD, a leading neurologist specializing in epilepsy, seizure disorders and neurodegenerative diseases, has joined the organization’s collaborative network. With a strong commitment to advancing epilepsy care and epilepsy-related neurodiagnostics in New Jersey, Dr. Mehta brings an unparalleled dedication to enhancing patient outcomes … Read more
Longmont, CO – Tekton Research, a prominent leader in clinical trials with a nationwide network of research facilities established in 2006, is excited to announce its recent partnership with Dr. Alex Reish. An esteemed osteopath specializing in migraines and chronic pain, Dr. Reish joins Tekton Research with a strong passion for innovative care and extensive … Read more